Growth Metrics

Merck (MRK) Cash from Financing Activities (2016 - 2025)

Merck (MRK) has disclosed Cash from Financing Activities for 17 consecutive years, with $4.8 billion as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities rose 257.89% to $4.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.9 billion through Dec 2025, up 72.67% year-over-year, with the annual reading at -$1.9 billion for FY2025, 72.67% up from the prior year.
  • Cash from Financing Activities for Q4 2025 was $4.8 billion at Merck, up from $2.6 billion in the prior quarter.
  • The five-year high for Cash from Financing Activities was $5.2 billion in Q4 2021, with the low at -$5.8 billion in Q1 2025.
  • Average Cash from Financing Activities over 5 years is -$989.3 million, with a median of -$2.2 billion recorded in 2021.
  • The sharpest move saw Cash from Financing Activities surged 311.48% in 2023, then crashed 392.43% in 2025.
  • Over 5 years, Cash from Financing Activities stood at $5.2 billion in 2021, then tumbled by 129.84% to -$1.6 billion in 2022, then plummeted by 44.47% to -$2.2 billion in 2023, then plummeted by 34.03% to -$3.0 billion in 2024, then skyrocketed by 257.89% to $4.8 billion in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $4.8 billion, $2.6 billion, and -$3.6 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.